Pfizer Inc
corporate_fare Company Profile
Pfizer Inc (NYSE:PFE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 54 items for PFE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for PFE spans 10-Q, 8-K.
Recent high-impact activity:
- Pfizer's LITFULO Shows Strong Repigmentation in Vitiligo Trials, FDA Submission Planned
- Florida AG Sues Pfizer Over COVID Vaccine Claims, Seeks Fines and Disgorgement
- Florida AG Sues Pfizer and CEO Bourla Over COVID Vaccine Marketing
- Pfizer's Trispecific Tilrekimig Hits Phase 2 Primary Endpoint in Atopic Dermatitis
- Pfizer Buys Metsera, Gains Monthly GLP-1 Obesity Drug with 12.3% Weight Loss
Financial Snapshot
Short Interest & Short Volume
4.90 days to coverFINRA reported short interest of 155,202,257 shares in PFE as of the September 15, 2026 settlement, a 2.4% increase from the prior period — about 4.9 days to cover at its recent average daily volume. On October 2, 2026, 49.4% of PFE volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.